In addition to the existing 3 applications Selfdiagnostics has filed previously, further 3 applications have been submitted in March 2017. One of the applications is in progress. All 7 patents will enable the company to protect its core technology from replication; guaranteeing continued company value and growth in the coming years.
Don’t miss the chance to meet us in Medica 2023, in Düsseldorf, Germany We’re tirelessly…
Upcoming participation in the highly anticipated Medical Biodefense Conference 2023 Selfdiagnostics is proud to announce…
Getting ready for mass production of Selfdiagnostics Multitest Covid-19 in Germany Selfdiagnostics has set up…
After years of research and development, Selfdiagnostics brings a portable and pocket-size test to the…
Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit is a rapid, accurate and straightforward point-of-care test kit…
Selfdiagnostics began development of a rapid SARS-CoV-2 test which enables faster detection of coronavirus infection…
For some time now, the healthcare system has been moving towards patients. However, we are…
The Estonian company Selfdiagnostics brings laboratory-grade precision home medical testing to ordinary users and offers…
